Spautin-1

Spautin-1

Catalog Number:
L002371305APE
Mfr. No.:
APE-B5873
Price:
$180
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          Description:
          IC50: 0.6 and 0.7 μM for USP10 and USP13 activity, respectively
          Autophagy is an important intracellular catabolic mechanism which mediates the degradation of cytoplasmic proteins and organelles. USP10 mediates the deubiquitination of p53, regulating deubiquitination the activities of USP10 and USP13 by Beclin1 provides a mechanism for Beclin1 to control the levels of p53. Spautin-1 is a novel autophagy inhibitor.
          In vitro: Spautin-1 promotes the degradation of Vps34 PI3 kinase complexes via inhibiting two ubiquitinspecific peptidases, USP10 and USP13, that target the Beclin1 subunit of Vps34 complexes. Spautin-1 had no effect on the growth and survival of Bcap-37 cells under normal culture conditions but dramatically enhanced cell death in glucose-free media. Under glucose-free conditions, western blotting for LC3 further confirmed that autophagy was induced, which was inhibited by spautin-1. Similar results were obtained with MCF-7 and BT549 cells. Therefore, spautin-1 can sensitize tumor cells to apoptosis under nutritional deprived conditions [1].
          In vivo: So far, there is no report to investigate the in vivo animal efficacy of spautin-1.
          Clinical trial: Up to now, spautin-1 is still in the preclinical development stage.

      • Properties
        • Alternative Name
          (Z)-1-(4-fluorophenyl)-N-(6-fluoroquinazolin-4(3H)-ylidene)methanamine
          CAS Number
          1262888-28-7
          Molecular Formula
          C15H11F2N3
          Molecular Weight
          271.26
          Appearance
          A solid
          Purity
          99.70%
          Solubility
          insoluble in H2O; ≥13.5 mg/mL in DMSO; ≥5.51 mg/mL in EtOH with ultrasonic
          Storage
          Store at -20°C

          * For Research Use Only

      • Reference
        • 1. Liang D, Wang HY, et al. "W941, a new PI3K inhibitor, exhibits preferable anti-proliferative activities against nonsmall cell lung cancer with autophagy inhibitors." Invest New Drugs. 2019 Dec 10. PMID:31823159
          2. Yeo SK, Paul R, et al. "Improved efficacy of mitochondrial disrupting agents upon inhibition of autophagy in a mouse model of BRCA1-deficient breast cancer." Autophagy. 2018;14(7):1214-1225. PMID:29938573

    We Also Recommend

    E3330

    $330

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.